Ipsen S.A. publishes its 2023 Consolidated Financial Statements

Aggregated presentation by day and by market Weekly report on share repurchases from 20th July to 24th July 2026       Name of the IssuerIdentify code of the IssuerTransaction dayIdentify code of the...

PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating Bylvay versus placebo for patients living with biliary atresia (BA) who have...